PlainRecalls
FDA Drug Low Class III Terminated

Rizatriptan Benzoate Orally Disintegrating Tablets 10mg, 18 Tablets (3 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods Pharma USA Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-094-41

Reported: November 3, 2021 Initiated: October 18, 2021 #D-0080-2022

Product Description

Rizatriptan Benzoate Orally Disintegrating Tablets 10mg, 18 Tablets (3 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods Pharma USA Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-094-41

Reason for Recall

Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

Details

Recalling Firm
MACLEODS PHARMA USA, INC
Units Affected
643,800 Blister Packs /888,336 Tablets
Distribution
Nationwide within the United States
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Rizatriptan Benzoate Orally Disintegrating Tablets 10mg, 18 Tablets (3 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods Pharma USA Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-094-41. Recalled by MACLEODS PHARMA USA, INC. Units affected: 643,800 Blister Packs /888,336 Tablets.
Why was this product recalled?
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 3, 2021. Severity: Low. Recall number: D-0080-2022.